Cell Analysis Market

Report Overview

The global cell analysis market was pegged at US$ 17.12 billion in 2020 and is expected to witness a CAGR of 7% during the forecast period.

Market Fundamentals  

Cell analysis is a broad term that can be applied to a range of different technologies. Cell analysis is performed to evaluate and measure the current state of cells, such as cell integrity, toxicity, viability, and various other research applications. An integral part of cell analysis is data collection, analysis, and export into a meaningful and useful format. It plays a vital role in gene identification, protein identification epigenomics, and other life science-related areas.

[653453434]

Market Dynamics

The global cell analysis market is mainly driven by the rising incidence of chronic diseases coupled with the application of cell analysis in personalized medicine, increasing drug discovery & development activities, and technological advancements. Furthermore, increasing funding for cell-based research is also likely to play a pivotal role in driving the market globally. However, the high cost of cell analysis instruments and experiments is likely to restrain the market growth to a certain extent.

Market Ecosystem

The global cell analysis market has been analyzed from four perspectives: Offering, Application, End User, and Region.

Cell Analysis Market by Offering

[8765453]

Based on offering, the market has been segmented into consumables, instruments, and software. The consumables segment is further categorized into reagents, assay kits, and others (microplates, etc.). Whereas, instruments segment is further categorized into microscopes, flow cytometry, qPCR, high-content screening (HCS) systems, cell microarrays, spectrophotometer, and others (cell counters, next-generation sequencing, etc.). The consumables segment dominated the market with the largest share owing to frequent purchases and high usability of consumables such as reagents & assay kits, unlike instruments & software.

Cell Analysis Market by Application

Based on application, the cell analysis market has been segmented into cell identification, cell viability, cell signaling pathway/signal transduction, cell proliferation, cell counting & quality control, target identification & validation, single-cell analysis, and others (cell interaction, cell structure study, etc.). The cell identification segment dominated the market with the largest share. The cell identification process helps in identifying blood cells depending on their size, presence/absence of nucleus in the cell, and shape of the nucleus. Furthermore, it also assists in identifying tumor cells with the help of spectroscopy and microfluidics. These factors are expected to drive the growth of the cell identification segment.

Cell Analysis Market by End User

Based on end-users, the cell analysis market has been segmented into hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies, academic and research institutes, and others (cell culture collection repositories, CROs, etc.). The pharmaceutical & biotechnology companies segment is expected to be the fastest-growing end-user segment during the forecast period. The growth of the segment can be mainly attributed to growing drug research & development activities. Cell analysis instruments & consumables are widely used in various stages of drug discovery, pharmacokinetics, toxicology, and clinical studies.

Cell Analysis Market by Region

Based on region, the global cell analysis market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (ROW). North America dominated the cell analysis market with the largest share, followed by the Asia Pacific. The large share of North America in the global market can largely be attributed to developed healthcare infrastructure, rising prevalence of chronic diseases, growing R&D activities, and growing government initiatives. Furthermore, the presence of prominent players in the region coupled with their continuous effort to launch technologically advanced cell analysis tools and instruments are also expected to propel the growth of the market.

Competitive Landscape

Some of the prominent players operating in the cell analysis market includes:-

• Beckman Coulter, Inc
• Thermo Fisher Scientific
• BD
• Merck KGaA
• Cytiva
• Agilent Technologies, Inc
• Olympus Corporation
• PerkinElmer Inc
• Promega Corporation
• Sysmex, among others

Strategic Developments

• In May 2020, Sartorius, launched the new Incucyte SX5 Live-Cell Analysis System, the latest in the company's line of live-cell analysis products. The Incucyte SX5 offers new capabilities, including novel optics, a new line of paired reagents, and purpose-built software to enable researchers to draw greater insight from every live cell experiment
• In Jan 2020, NanoCellect Biomedical Inc. announced a distribution and partnership agreement with China-based Novogene to distribute NanoCellect's WOLF Cell Sorter, N1 Single-Cell Dispenser, consumables, and software in China. In addition, Novogene will be adding the WOLF platform to advance their leading-edge genomic services and solutions business
• In Jun 2019, Sony Corporation ("Sony") announced the launch of its ID7000 flagship spectral cell analyzer, a new flow cytometer that achieves streamlined multicolor cell analysis for more than 44 colors. Incorporating Sony novel spectral technology with up to 7 lasers and 1886 detectors the system enables researchers to detect dim and rare populations from heterogeneous cell populations expanding the boundaries of cell analysis
• In Sept 2018, Agilent Technologies Inc. signed a definitive agreement to acquire privately-owned ACEA Biosciences Inc. (ACEA), a developer of cutting-edge cell analysis instruments for life science research and clinical diagnostics, for $250 million in cash to expand their cell analysis footprint

Frequently Asked Questions About This Report